Exercise intensity and function Diabetes Care Publish Ahead of Print, published online July 10, 2009

Effects of Exercise Training Intensity on Pancreatic Beta-Cell Function

Running Head: Exercise intensity and beta cell function

Cris A. Slentz, PhD, Charles J. Tanner, MS, Lori A. Bateman, MS, Michael T. Durheim MD, Kim M. Huffman, MD, PhD, Joseph A. Houmard, PhD and William E. Kraus, MD

Divisions of Cardiovascular Medicine (CAS, LAB, MTD, WEK) & Rheumatology (KMH), Department of Medicine, and Duke Center for Living (WEK); Duke University Medical Center, Durham, N.C. Department of Exercise and Sports Science and Human Performance Laboratory, (CJT, JAH), East Carolina University, Greenville, NC

Corresponding author: Cris A. Slentz, PhD Email: [email protected]

Submitted 8 January 2009 and accepted 7 July 2009.

Clinical trial reg. no. NCT0020093, clinicaltrials.gov

This is an uncopyedited electronic version of an article accepted for publication in Diabetes Care. The American Diabetes Association, publisher of Diabetes Care, is not responsible for any errors or omissions in this version of the manuscript or any version derived from it by third parties. The definitive publisher- authenticated version will be available in a future issue of Diabetes Care in print and online at http://care.diabetesjournals.org.

Copyright American Diabetes1 Association, Inc., 2009

Exercise intensity and beta cell function

Objective: resistance and beta cell dysfunction both are important contributors to the pathogenesis of . Exercise training improves insulin sensitivity, but its effects on beta cell function are less well studied.

Methods: Sedentary, overweight adults were randomized to control or one of three eight-month exercise programs: 1) low-amount/moderate-intensity; 2) low-amount/vigorous-intensity; or 3) high-amount/vigorous-intensity. Of 387 randomized, 260 completed the study and 237 had complete data. Insulin sensitivity (SI), acute insulin response to glucose (AIRg) and the Disposition Index (DI = SI x AIRg) were modeled from an intravenous .

Results: Compared to controls, all three training programs led to increases in DI. However, the moderate-intensity group experienced a significantly larger increase in DI than either of the vigorous-intensity groups and through a different mechanism. The high-amount/vigorous- intensity group improved SI and had a compensatory reduction in AIRg, whereas the moderate- intensity group had a similar improvement in SI, but almost no reduction in AIRg. Importantly, the inactive control group experienced a significant increase in fasting glucose.

Conclusions: To the extent that the disposition index accurately reflects beta cell function, we observed that both moderate and vigorous intensity exercise-training improved beta cell function, albeit through distinct mechanisms. It is not clear which of these mechanisms is preferable for maintenance of metabolic health. While moderate-intensity exercise led to a larger improvement in DI, which may reflect a transition toward a more normal DI, longer term investigations would be necessary to determine which was more effective at reducing diabetes risk.

ClinicalTrials.gov Identifier: NCTOO20093

2

Exercise intensity and beta cell function

nsulin resistance and pancreatic amounts and intensities of exercise training beta cell dysfunction are important on numerous cardiometabolic risk factors. I contributors to the pathogenesis of This report focuses on the STRRIDE findings type 2 diabetes (1-3). Sedentary, overweight pertinent to beta cell function. and obese individuals are generally insulin resistant, but often are able to maintain METHODS normal glucose tolerance through These data are part of the STRRIDE compensatory increases in pancreatic insulin project described in detail previously (11; 12). secretion. Therefore, in order to fully assess Subjects: Subjects were 40 to 65 and understand the progression to diabetes, years, sedentary, overweight or mildly obese the degree of should be (BMI 25 to 35 kg/m2) and moderately interpreted relative to insulin secretion. dyslipidemic (either LDL-cholesterol 130-190 The relationship between insulin mg/dL; and/or HDL-cholesterol < 40 mg/dL resistance and insulin secretion is hyperbolic for men, or < 45 mg/dL for women). Women and is sometimes referred to as the hyperbolic were postmenopausal. Exclusion criteria law of glucose tolerance (1-3; 4). This included medications that alter carbohydrate relationship is represented by the disposition metabolism, diabetes, inability to exercise, index (DI) – the product of SI (insulin and history of hypertension or heart disease. sensitivity index) and AIRg (acute insulin The protocol was approved by the relevant response to intravenous glucose), both of institutional review boards and subjects which are modeled as parameters in the provided written informed consent. intravenous glucose tolerance test through the Exercise training: All subjects were Minimal Model of Bergman (5). DI randomly assigned to one of three training physiologically represents the degree to which groups or a control group. The exercise the pancreatic beta cells are able to fully or groups were: 1) high-amount/vigorous- partially compensate for changes in insulin intensity; 2) low-amount/vigorous-intensity; sensitivity, and is an accepted measure of and 3) low-amount/moderate-intensity. The pancreatic beta cell function. In normal high-amount/vigorous-intensity group individuals, DI is relatively high, however in prescription was to expend 23 kilocalories per those along the progression from normal to kilogram body weight per week exercising at T2D, DI becomes progressively lower, 65 to 80% peak VO2 (approximately reflecting a decreased ability of the calorically equivalent to 20 miles per week of to fully compensate for increases in insulin walking or jogging). For low- resistance (6-10). amount/vigorous-intensity, the prescription The beneficial effect of exercise on was to expend 14 kilocalories/kg/wk insulin sensitivity is well known. However, (approximately calorically equivalent to 12 the effects of exercise on AIRg and DI have miles per week). For the low- not been well-studied. We are not aware of amount/moderate-intensity, subjects were to any studies that have investigated the effects expend 14 kilocalories/kg/wk at 40 to 55% of different amounts or intensities of exercise peak VO2 (see Table 1). Exercise modes on AIRg or DI. The purpose of STRRIDE included treadmill and elliptical trainers. All (Studies of a Targeted Risk Reduction exercise sessions were verified by direct Intervention through Defined Exercise), a supervision or recordable heart rate monitors. large, randomized, controlled clinical trial, Crossover controls: Participants were was to investigate the effects of different assured that if they were assigned to the

3

Exercise intensity and beta cell function

control group, after this period, they would be determined independently for each of the four randomized into one of the exercise groups. groups by two-tailed t-tests. To determine This was important for recruiting subjects to differential training effects between the an exercise study. Subjects who finished both exercise-only groups for DI, SI or AIRg, the control period and then were randomized ANOVA with Fisher’s post hoc test were to and finished one of the exercise used. P-values < 0.05 for individual t-tests interventions, had data for both control and for post hoc tests were considered changes and exercise changes. To maintain statistically significant. the independent relation between the control changes and the exercise intervention RESULTS changes, we have not used both control and Of the 387 subjects randomized in exercise data from the same subject when STRRIDE, 260 completed the study and 127 comparing exercise response to controls. (32.8%) dropped out. Of the 260, 237 had However, when exercise only questions were complete pre- and post-intervention data for of primary interest – as in the present study, the glucose tolerance test. Table 1 describes we have used the exercise change data, but the exercise interventions in detail. not the control data from these subjects. This The results for DI, AIRg and SI are approach increases the statistical power for presented in Table 2 and also Figure 1. In comparisons between exercise interventions Table 2 the data show that DI was because it increases the number of subjects in significantly improved for the low- each of the exercise groups. All data from amount/moderate-intensity and for the high- subjects that completed exercise-training are amount/vigorous-intensity groups. The low- included in these analyses; the control data amount/vigorous group was on the border of are included only for non-statistical significance (P = 0.063). Surprisingly, the comparisons. improvement in DI that occurred in the Insulin action measures: Insulin moderate-intensity group was significantly action was determined with a three-hour greater than both of the vigorous-intensity intravenous glucose tolerance test (5). groups (Figure 1). All three groups Glucose (50%) was injected through a experienced significant improvements in SI. catheter at 0.3 g per kg body mass. Insulin, The magnitude of the improvement for the 0.025 U per kg body mass, was injected at moderate-intensity group was significantly minute 20. Twenty-six blood samples were greater than that for the same amount of obtained centrifuged, and stored at –80oC. exercise at a vigorous intensity, indicating a Insulin was measured by immunoassay clear beneficial effect of moderate intensity (Access Immunoassay System, Beckman over vigorous intensity for SI. Interestingly, Coulter, Fullerton, CA) and glucose with an only the high-amount/vigorous-intensity oxidation reaction (YSI 2300, Yellow group showed the expected compensatory Springs, OH). Insulin sensitivity index (SI), decrease in insulin response to the glucose acute phase insulin response to intravenous challenge (AIRg decreased by 15.2% in this glucose (AIRg) and disposition index (DI) group). There was virtually no compensatory were calculated using Bergman’s minimal decrease in AIRg in the group that had the model (5). greatest improvement in SI, i.e., the moderate Statistical methods: Baseline intensity group (AIRg decreased only 2.2%). differences between the exercise groups were When gender was added to the model, there evaluated via ANOVA with Fisher’s post hoc were no significant gender differences or test. Pre to post-training changes were

4

Exercise intensity and beta cell function

gender by group interactions for DI, AIRg or (P=0.063). Although DI has been shown to SI. predict the development of type 2 The inactive control group diabetes(13), additional studies would be experienced a significant increase in fasting necessary to determine if the greater effect of glucose, indicating a progression towards moderate intensity exercise on DI actually diabetes (Table 2). We observed significant translated into a greater reduction in diabetes deterioration in several other variables risk. including fasting insulin, HOMA, body mass, A second observation related to the visceral fat and cardiovascular fitness in the early phase pancreatic beta cell responses to inactive control group. All exercise groups the intravenous glucose challenge. While experienced significantly reduced moderate intensity exercise resulted in the triglycerides, but the low-amount/moderate- largest improvement in SI, this group intensity group had the greatest decrease - experienced almost no compensatory decrease significantly greater than the same amount of in first phase insulin secretion (AIRg vigorous exercise (P<0.035) and trending decreased 2%, non significant) – together toward a greater decrease than even the high- these effects resulted in a larger improvement amount group (P<0.085). The moderate in DI in this group versus the others. High- intensity group had the greatest decrease in amount/vigorous-intensity exercise resulted in fasting insulin; however, this difference was a similar increase in SI, however this group not significant (P<0.19). Only the high did have a compensatory decrease in insulin amount of exercise was sufficient to reduce secretion (AIRg decreased 15%, P = 0.007) – visceral fat. All exercise programs resulted in together this resulted in a smaller significant improvements in peak oxygen improvement in DI in this group versus the consumption. moderate intensity group. All data were investigated for outliers. It is not altogether clear which of these We identified two outliers for DI change (> 4 is a preferable response for metabolic health. SD’s above the mean). Removal of these two The subjects in this trial had DI levels that individuals had no effect on the significance were well below those observed in healthy of any analyses or on the interpretation of any individuals (our average baseline DI was of the findings, and as a result, they were ~1400 compared to other reports for normal retained in all analyses. individuals ranging from 2000 - 2800 (6; 8; 9). Also, in overweight/obese subjects, AIRg DISCUSSION decreases progressively across levels of The Disposition Index (DI = AIRg x glucose tolerance (from normal to impaired to SI) is an accepted measure of pancreatic beta diabetic)(8; 9). Our own baseline data show a cell function and predicts the development of clear and progressive decrease in AIRg (and type 2 diabetes(13). The major finding of the also DI and SI) even across tertiles of normal present study was that moderate intensity glucose (< 100 mg/dl; data note shown). exercise training improved disposition index Therefore the response experienced by the significantly better than did vigorous intensity moderate intensity intervention might reflect a exercise in sedentary, overweight, moderately transition towards a more normal and perhaps dyslipidemic subjects. It is important to note healthier disposition index. On the other that all three exercise-training regimens hand, consistent findings of exercise-induced resulted in improved DI, although the low- reductions in insulin levels (area under the amount/vigorous-intensity group was just on curve) in response to an oral glucose the border of statistical significance challenge(14), and decreased insulin secretion

5

Exercise intensity and beta cell function

with hyperglycemic clamps(15), have been a more vigorous exercise. Recently, in a study hallmark finding in exercise research – designed to investigate exercise training at an although the majority of these studies have intensity that optimizes fat oxidation been in response to vigorous exercise only. (FATmax), Venables and Jeukendrup(24) The specific mechanisms responsible reported that moderate intensity training for these observations are not obvious. In improved both SI and fat oxidation more than previous publications in this study cohort, we the same amount of interval exercise training. have observed that the high-amount group, The robust effects observed with compared to both low-amount exercise moderate intensity exercise in these studies groups, experienced greater reductions in may be the result of improved fat oxidation body weight, body fat, waist circumference leading to a reduction in lipotoxcity in (16), visceral and abdominal subcutaneous fat skeletal muscle, liver and/or pancreas. (17), greater and more widespread Schenk and Horowitz recently observed that improvements in lipids and lipoproteins (11), acute exercise increases triglyceride synthesis and greater improvements in cardiovascular in skeletal muscle and prevents fatty acid- fitness (18). With the exception of fitness, induced insulin resistance (25). Although exercise intensity was not a factor they only studied one exercise intensity contributing to these differences; rather, the (moderate), they reported numerous responses effect was due to a greater amount of in skeletal muscle that likely explain the acute exercise. Therefore, it seems clear, at least in effects, including enhanced key lipogenic the present study, that the greater enzymes, an increase in muscle triglyceride improvement in DI resulting from moderate synthesis, reduced partitioning of fatty acids intensity exercise cannot be explained by the towards ceramide and diacylglycerol (both factors more favorably modulated by vigorous hypothesized to be causally related to insulin exercise. In contrast, we have also previously resistance), and a suppression of pro- reported that the moderate-intensity group inflammatory response. It seems likely that experienced a number of unexpected moderate intensity exercise, which relies metabolic benefits including: 1) a greater more heavily on fat oxidation, may be more reduction in plasma triglycerides (both acute effective than vigorous exercise in creating and chronic), compared to both vigorous these specific adaptations. Our observation of intensity groups (11; 19); 2) a greater increase greater acute and chronic reductions in in insulin sensitivity at both 24 hours after the plasma triglycerides with moderate compared last bout and after 14 days after exercise to vigorous exercise (19) supports this withdrawal (20; 21) - significantly different hypothesis. than the same amount of vigorous exercise; Finally, another important finding of and 3) a greater improvement in metabolic the present study was the clinically and syndrome score compared to the same amount statistically significant increase of nearly 3 of vigorous exercise training (22). mg/dL in fasting glucose that occurred in the It is well known that expending the control group. There were no significant same number of calories while exercising at a changes in fasting glucose in any exercise moderate intensity compared to vigorous group emphasizing the important preventive intensity results in a lower respiratory effects of regular exercise on the deterioration exchange ratio (RER), the ratio of CO2 of glucose control that occurs with physical production to O2 consumption (23; 24) and inactivity, positive energy balance and weight thus reflecting a greater percentage of fat gain. oxidation for energy when compared with

6

Exercise intensity and beta cell function

In summary, eight months of with a similar improvement in insulin continued physical inactivity in sedentary sensitivity but with almost no reduction in overweight and obese individuals with insulin secretion. While the moderate moderate dyslipidemia, led to a significant intensity intervention might reflect a increase in fasting glucose levels indicating a transition towards a more normal disposition progression towards type 2 diabetes. Further, index in sedentary, moderately dyslipidemic to the extent that the disposition index individuals, longer term investigations would accurately reflects beta cell function, we be necessary to confirm a superior observed that both moderate and vigorous improvement in diabetes risk. intensity exercise improved beta cell function, but through distinct mechanisms. The high- ACKNOWLEDGMENTS amount of vigorous intensity exercise was Supported by National Institute of associated with an improvement in insulin Health Grant HL-57354. sensitivity and a compensatory decrease in STRRIDE (Studies of a Targeted Risk insulin secretion. The low-amount of Reduction Intervention through Defined moderate intensity exercise was associated Exercise)

7

Exercise intensity and beta cell function

REFERENCES 1. Kahn S, Hull R, Utzschneider K: Mechanisms linking obesity to insulin resistance and to type 2 diabetes. Nature 444:840-846, 2006 2. Ferrannini E, Gastaldelli A, Miayzaki Y, Matsuda M, Pettiti M, Natali A, Mari A, DeFronzo R: Predominant role of reduced beta-cell sensitivity to glucose over insulin resistance in impaired glucose tolerance. Diabetologia 46:1211-1219, 2003 3. Bergman R: Banting Lecture 2006: Orchestration of glucose homeostasis - from a small acorn to the California Oak. Diabetes 56:1489-1500, 2007 4. Stumvoll M, Tataranni P, Bogardus C: The hyperbolic law - a 25-year perspective. Diabetologia 48:207-209, 2005 5. Bergman R, Finegood D, Ader M: Assessment of insulin sensitivity in vivo. Endocr Rev 6:45- 86, 1985 6. Elder D, Prigeon R, Wadwa P, Dolan L, D'Alessio D: Beta cell function, insulin sensitivity, and glucose tolerance in obese diabetic and nondiabetic adolescents and young adults. J Clin Endo & Metab 91:185-191, 2006 7. Cnop M, Vidal J, Hull R, Utzschneider K, Carr D, Schraw T, Scherer P, Boyko E, Fujimoto W, Kahn S: Progressive loss of beta cell function leads to worsening glucose tolerance in first- degree relatives of subjects with type 2 diabetes. Diabetes Care 30:677-682, 2007 8. Hong J, Gu W, Zhang Y, Yang Y, Shen C, Xu M, Li X, Wang W, Ning G: The interplay of insulin resistance and beta cell dysfunction involves the development of type 2 diabetes in chinese obeses. Endocr 31:93-99, 2007 9. Utzschneider K, Prigeon R, Carr D, Hull R, Tong J, Shofer J, Retzlaff B, Knopp R, Kahn S: Impact of differences in fasting glucose and glucose tolerance on the hyperbolic relationship between insulin sensitivity and insulin responses. Diabetes Care 29:356-362, 2006 10. Kahn S: Clinical Review 135: The importance of beta cell failure in the development and progression of type 2 diabetes. J Clin Endo & Metab 86:4047-4058, 2001 11. Kraus W, Houmard J, Duscha B, Knetgzer K, Wharton M, McCartney J, Bales C, Henes S, Samsa G, Otvos J, Kulkarni K, Slentz C: Effects of the amount and intensity of exercise on plasma lipoproteins. New Engl J Med 347:1483-1492, 2002 12. Kraus W, Torgan C, Duscha B, Norris J, Brown S, Cobb F, Bales C, Annex B, Samsa G, Houmard J, Slentz C: Studies of a targeted risk reduction intervention through defined exercise (STRRIDE). Med Sci Sports Exerc 33:1774-1784, 2001 13. Utzschneider K, Prigeon R, Faulenbach M, Tong J, Carr D, Boyko E, Leonetti D, McNeely M, Fujimoto W, Kahn S: Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels. Diabetes Care 32:335-341, 2009 14. Holloszy J, Schultz J, Kusnierkiewicz J, Hagberg J, Ehsani A: Effects of exercise on glucose tolerance and insulin resistance. Brief review and some preliminary results. Acta Medica Scandinavica - Supplementum 711:55-65, 1986 15. Arciero P, Vukovich M, Holloszy J, Racette S, Kohrt W: Comparison of short-term diet and exercise on insulin action in individuals with abnormal glucose tolerance. J Appl Physiol 86:1930-1935, 1999 16. Slentz C, Duscha B, Johnson J, Ketchum K, Aiken L, Samsa G, Houmard J, Bales C, Kraus W: Effects of the amount of exercise on body weight, body composition, and measures of central obesity. STRRIDE-a randomized controlled study. Archives of Internal Medicine 164:31-39, 2004

8

Exercise intensity and beta cell function

17. Slentz C, Aiken L, Houmard J, Bales C, Johnson J, Tanner C, Duscha B, Kraus W: Inactivity, exercise and visceral fat. STRRIDE: a randomized, controlled study of exercise intensity and amount. J Appl Physiol 99:1613-1618, 2005 18. Duscha B, Slentz C, Johnson J, Houmard J, Bensimhon D, Knetgzer K, Kraus W: Effects of exercise training amount and intensity on peak oxygen comsumption in middle-aged men and women at risk for cardiovascular disease. Chest 128:2788-2793, 2005 19. Slentz C, Houmard J, Johnson J, Bateman L, Tanner C, McCartney J, Duscha B, Kraus W: Inactivity, exercise training and detraining, and plasma lipoproteins. STRRIDE: a randomized, controlled study of exercise intensity and amount. J Appl Physiol 103:432-442, 2007 20. Houmard J, Tanner C, Slentz C, Duscha B, McCartney J, Kraus W: Effect of the volume and intensity of exercise training on insulin sensitivity. J Appl Physiol 96:101-106, 2004 21. Bajpeyi S, Tanner C, Slentz C, Duscha B, McCartney J, Hickner R, Kraus W, Houmard J: Effect of exercise intensity and volume on the persistence of insulin sensitivity during training cessation. J Appl Physiol in press, 2009 22. Johnson J, Slentz C, Houmard J, Samsa G, Duscha B, Aiken L, McCartney J, Tanner C, Kraus W: Exercise training amount and intensity effects on metabolic syndrome (from Studies of a Targeted Risk Reduction Intervention through Defined Exercise). Am J Cardiol 100:1759, 2007 23. Tolfrey K, Doggett A, Boyd C, Pinner S, Sharples A, Barrett L: Postprandial Triacylglycerol in adolescent boys: a case for moderate exercise. Med Sci Sports Exerc 40:1049-1057, 2008 24. Venables M, Jeukendrup A: Endurance training and obesity: effect on substrate metabolism and insulin sensitivity. Med Sci Sports Exerc 40:495-502, 2008 25. Schenk S, Horowitz J: Acute exercise increases triglyceride synthesis in skeletal muscle and prevents fatty acid-induced insulin resistance. J Clin Invest 117:1690-1698, 2007

9

Exercise intensity and beta cell function

Table 1: Exercise prescription, adherence by group and substrate use

Low Amount/ Low Amount/ High Amount/ Variables Moderate Intensity Vigorous Intensity Vigorous Intensity N = 57 N = 58 N = 64 Prescription & Actual exercise dose Intensity (% peak 40-55% 65-80% 65-80% oxygen consumption) Prescription amount 12 12 20 (miles/wk)* Prescription amount 1220 ± 212 1230 ± 177 2020 ± 307 (Kcal/wk) Prescription Time 201 ± 37 125 ± 28 207 ± 44 (min/wk) Adherence (%) 88 ± 14 90 ± 12 84 ± 15 Actual amount 10.6 10.8 16.8 (miles/wk)† Actual Time (min/wk)‡ 176 ± 36 113 ± 28 172 ± 41 Frequency 3.5 ± 0.8 2.9 ± 0.5 3.6 ± 0.8 (sessions/wk) Respiratory Exchange 0.907 ± 0.05 *** 0.960 ± 0.06 0.961 ± 0.04 Ratio Fat Utilization Energy from Fat (%) 30.2% 12.6% 12.6% Kcals from Fat (Kcal) 368 155 255

Values are shown as means ± SD. *Prescription amount is presented as the approximate number of miles/wk that are calorically equivalent to the prescribed kcal/wk of 14 kcal/kg/wk for the low dose groups and 23 kcal/kg/wk for the high dose group. †Actual amount = Prescription amount x Adherence for each group (therefore no SD). ‡Actual time = Prescription time x Adherence for each subject. Respiratory Exchange Ratios (RER) were obtained during the submaximal exercise bout that were performed to determine the correct exercise intensity (i.e. 40-55% for the moderate intensity group and 65-80% for the vigorous intensity groups). *** indicates that the RER for the moderate intensity group was significantly different from both vigorous groups P< 0.0005).

10

Exercise intensity and beta cell function

TABLE 2. Baseline and Change Scores for Disposition Index, AIRg, Insulin Sensitivity, metabolic variables, body weight and body composition variables by group Control Low-Amount / Moderate-Intensity Low-Amount / Vigorous-Intensity High-Amount / Vigorous-Intensity

n = 58 ( 30 men; 28 women ) n = 57 ( 30 men; 27 women ) n = 58 ( 33 men; 25 women ) n = 64 ( 38 men; 26 women )

Baseline Change P-value Baseline Change P-value Baseline Change P-value Baseline Change P-value

Disposition Index 1562 -65 NS * 1270 742 0.002 1533 255 0.063 1305 255 0.004

(x 10-5 min-1) ± 1444 ± 893 ± 1147 ± 1680 ± 1362 ± 1023 ± 1121 ± 688

AIRg 490.6 22 NS 457.3 -10 NS 445.5 -43 0.14 505.6 -77 0.007

(pmol/l) ± 431 ± 233 ± 334 ± 207 ± 353 ± 216 ± 427 ± 218

Insulin Sensitivity 3.5 -0.35 0.12 3.1 1.7 < 0.0001 3.7 0.8 0.001 3.2 1.1 < 0.0001

(x 10-5 min-1 / pmol) ± 2.1 ± 1.7 ± 2.2 ± 2.5 ± 2.1 ± 1.8 ± 2.5 ± 2.1

Fasting Glucose 91 3.2 0.005 94 -0.1 NS 93 1.2 NS 94 0.5 NS

(mg / dl) ± 11 ± 8 ± 9+ ± 9 ± 8 ± 9 ± 10 ± 10

Fasting Insulin 8.5 0.9 0.04 10.3 -2.5 0.002 8.8 -1.5 0.008 9.6 -1.3 0.002

(uU / ml) ± 4.3 ± 3.3 ± 8.1 ± 5.6 ± 5.9 ± 4.1 ± 5.6 ± 3.3

11

Exercise intensity and beta cell function

HOMA 2.0 0.28 0.011 2.5 -0.58 0.003 2.1 -0.36 0.014 2.3 -0.30 0.009

(mg/dl x uU/ml) ± 1.2 ± 0.8 ± 1.9 ± 1.4 ± 1.6 ± 1.1 ± 1.4 ± 0.9

Triglycerides 147 5 NS 171 -35 0.002 143 -16 0.02 155 -21 0.002

(mg / dl) ± 71 ± 43 ± 108 ± 76 ± 67 ± 49 ± 84 ± 50

Body Mass (kg) 88 0.88 0.007 87 -0.81 0.012 88 -0.96 0.003 88 -0.15 < 0.0001

± 14 ± 2.4 ± 15 ± 2.4 ± 13 ± 2.3 ± 13 ± 2.7

Visceral Fat (cm2) 163 13 0.003 174 -2.1 NS 158 -4.6 NS 168 -12 0.018

± 66 ± 29 ± 77 ± 30 ± 56 ± 36 ± 72 ± 35

VO2 peak 27 -0.7 0.03 27 1.8 < 0.0001 29 3.4 < 0.0001 28 5.0 < 0.0001 (ml/kg/min) ± 6 ± 2 ± 6 ± 2 ± 6 ± 3 ± 5 ± 3

Data expressed as mean + SD. *NS – indicates P > 0.30 and therefore not significant. All other P values (< 0.30) are shown. AIRg – acute insulin response to glucose challenge; HOMA ((fasting glucose X fasting insulin) / 22.5) – indicator of insulin sensitivity during fasting conditions.

12

Exercise intensity and beta cell function

Figure 1. The effects of exercise amount and intensity on Changes in Disposition Index (Panel A), Insulin Sensitivity (Panel B), and Acute Insulin Response to glucose (AIRg; Panel C) are shown. Data are means plus or minus standard error bars. All P-values < 0.10 for group comparisons are reported. For: Low Amount / Moderate Intensity (n = 57); Low Amount / Vigorous Intensity (n = 58); High Amount / Vigorous Intensity (n = 64).

13